Buehler? Buehler? just what i thought, no word on new products or approvals. What do you think will be said when we don't hit our goals for the end of the year? Look forward to 2006!
I heard the group responsible for the ovarian work was transferred to Becton Dickinson over a year ago. Don't expect anything to come of it. Useless ASR's are what we're stuck with on cervical and breast. Spin, spin, spin.
Yeah, on top of that, they have likely chosen the weaker money maker on the molecular breast side (between staging vs. screening). It only gets worse for the cervical market with Merck and GSK offering HPV vaccines later this year. Going nowhere fast with a weak Regulatory department, too. We're beginning to take on water.
who's in charge now? is there still a NSM? who are the regionals? wondering who is still there and who has 'seen the light'
